Skip to main content
Novo Nordisk A/S
Healthcare · Drug Manufacturers - General
Made on Aug 14, 2026
Price at call $46.72
6-month call Bull +12.2%
Target by Feb 2027 $52.40
Great value below $42.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +12.2% to $52.40
Predicted High $52.40 at 6 months
Predicted Low $45.40 at 1 month
Max Drawdown (predicted) -2.8%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 14, 2026 3:26 am
Bull NVO trends higher to $52.40 (+12.2% from $46.72) by Feb 2027. dip-then-recover
ThesisNVO trades at a discount to fair value but sentiment is deeply negative as GLP-1 mindshare rotates to Lilly. Expect near-term drift lower or flat as narrative headwinds dominate, then gradual mean-reversion toward the composite fair value as valuation gravity and prior earnings-beat cadence reassert. Endpoint lands modestly below the deterministic baseline given sentiment drag.
Invalidated ifBreak below the $42 attractive-value line on sustained volume, or Lilly headline that structurally cuts NVO GLP-1 share estimates
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $46.72 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 14, 2026 $46.72 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 28, 2026 $43.14–$50.30 typical range · internal point $46.10 ±7.7% 6/10 Sentiment drag persists, no catalyst, mild drift lower
1 month Sep 14, 2026 $41.53–$51.91 typical range · internal point $45.40 ±11.1% 6/10 GLP-1 narrative rotation to Lilly continues weighing
2 months Oct 14, 2026 $45.90 -1.8% 5/10 Value buyers begin nibbling near bear scenario floor
3 months Nov 14, 2026 $48.50 +3.8% 5/10 Earnings likely in window, beat cadence supports bounce
4 months Dec 14, 2026 $50.20 +7.4% 4/10 Post-print stabilization, valuation gravity kicks in
5 months Jan 14, 2027 $51.50 +10.2% 4/10 Gradual convergence toward composite fair value
6 months Feb 14, 2027 $52.40 +12.2% 4/10 Mean reversion toward baseline, sentiment partially fades

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $53.47 (+14.4%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 0 degraded · 1 note — follow the chain top-down (cause → effect).
  • Note
    Valuation anchor absent: anchored_pe.
    anchor:anchored_pe

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$46.72
Composite fair value$56.02
Signal-adjusted fair value$73.02
DCF fair value$63.23
Anchored-PE fair value
Buy-below (value lens)$42.00
Value net score+34
Value confidence6 / 10
Quality net score+51
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 45.5%  3m 38.5%  6m 43.6%  
Daily σ (realism noise)2.4%
Beta vs S&P 500 1m -0.95  3m -0.27  5m 0.39  
Trailing 6-month return-4.1%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 30, 2026 14d behind NVO-20260730-180604-92c8
ext-forensic-memo Aug 12, 2026 1d behind ext-NVO-20260812-132303-e603
ext-lens-quality Aug 12, 2026 1d behind ext-NVO-20260812-132303-e603
ext-lens-sentiment Aug 12, 2026 1d behind ext-NVO-20260812-132303-e603
ext-lens-value Aug 12, 2026 1d behind ext-NVO-20260812-132303-e603
scenario-valuation Aug 14, 2026 freshest NVO-20260730-180604-92c8
valuation-synthesis Aug 14, 2026 freshest NVO-20260730-180604-92c8

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

4 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 20, 2026 v0.6.0 Bull $46.42 $53.40 +15.0% Feb 2027 view
Aug 14, 2026 v0.6.0 Bull $46.72 $52.40 +12.2% Feb 2027 viewing
Aug 6, 2026 v0.6.0 Bull $44.53 $51.50 +15.7% Feb 2027 view
Aug 1, 2026 v0.6.0 Bull $47.08 $55.80 +18.5% Feb 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.